- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04887987
Effects of Lumbar Strengthening Training Plus Photobiomodulation on Non-specific Low-back Pain.
September 8, 2023 updated by: Andreo Fernando Aguiar, Universidade Norte do Paraná
Effects of Lumbar Strengthening Training Combined With Photobiomodulation Therapy on Functional and Psychological Aspects in Young and Older Adults With Chronic Non-specific Low Back Pain: a Randomized, Placebo-controlled Clinical Trial.
The present project aims to investigate the effects of lumbar strengthening training combined with photobiomodulation therapy (PBMT) on functional and psychological aspects in young and older adults with chronic non-specific low back pain.
We hypothesized that lumbar strengthening training combined with PBMT should promote greater improvement on functional and psychological variables compared to strengthening training alone (placebo PBMT).
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The purpose of this study will be to investigate the effects of lumbar strengthening training combined with photobiomodulation therapy (PBMT) therapy by light-emitting diode (LED) on functional and psychological aspects in young and older adults with chronic non-specific low back pain.
Initially, all participants will be submitted for a 2-wk familiarization period with physical tests, and then randomized into two groups (N = 16/group): lumbar strengthening training combined with LED PBMT (TR+LED) and lumbar strengthening training combined with placebo PBMT (TR+PLA).
Both groups will be submitted to a supervised 8-wk training program (3 x/week) involving a specific lumbar extension exercise on the Roman bench and four complementary exercises to improve core strength and spine stabilization.
The groups will receive their respective PBMT (LED or placebo) 30 minutes before each training session, through a device containing 264 LEDs (132 LEDs of 660 nm and 132 LEDs of 850 nm), which will be placed on the lumbar region (between L1 and L5) with the participants lying in the prone position.
The placebo LED will be applied with the device turned off.
Participans will be blinded to PBM treatments.
The following variables will be assessed at pre and post-training: anthropometric, body composition by bioimpedance, level of physical activity by International Physical Activity Questionnaire (IPAQ), maximal voluntary isometric contraction (MVIC) for lumbar extension exercise, short physical performance battery (SPPB), postural balance on a force platform, Schober test for lumbar spine flexion, Tampa Scale of kinesiophobia (TSK), Fear Avoidance Beliefs Questionnaire (FABQ), pain catastrophizing scale (PCS), quality of life by WHOQOL, oswestry disability index (ODI), Roland Morris disability questionnaire (RMDQ), McGILL pain questionnaire, and visual analogue scale (VAS).
Shapiro-Wilk and Levene tests will be used to test the normality and homogeneity of the measurements, respectively.
Two-way ANOVA (group x time) tests for repeated measures will be performed to assess changes over time and between groups for all dependent variables.
Violation of sphericity will adjust using Greenhouse-Geisser correction.
The Bonferroni post-hoc test will detect specific differences between groups.
When appropriate, the percentage of change (∆%) will be reported according to the following equation: ∆% = [(pre-average post average) / pre-average mean] × 100.
Values will be express as mean ± standard deviation.
O significance level α will be 0.05.
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Paraná
-
Londrina, Paraná, Brazil, 86.041-140
- Universidade Norte do Paraná
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Men and women aged 18-80 years
- To be eutrophic (BMI: 25-27 kg/cm2)
- Self-report of recurrent (≥ 3 x/week) or continuous episodes of nonspecific low back pain for at least 3 months, comprising the lumbar region between L1-L5
- To be physiscally active according to the International Physical Activity Questionnaire (IPAQ)
Exclusion Criteria:
- To present a history of musculoskeletal disorders that could affect muscle function
- To make use of medicines that could affect muscle function.
- To present low back pain of specific etiology, such as: tumor, herniated disc, facet syndrome, canal stenosis, among others.
- To have used ergogenic supplements and anabolic steroids for at least six months before study
- To present severe skin diseases in the lumbar region, such as: erysipelas, eczema, dermatitis, psoriasis and urticaria
- To have restrictions for exercises practice considering Physical Activity Readiness Questionnaire (PAR-Q) responses.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Lumbar strengthening training combined with LED PBMT (TR+LED)
Each participant will be submitted to a 8-wk lumbar strengthening training program and will receive the LED PBMT 30 minutes before each training session.
|
Participants will be submitted to a supervised 8-wk training program (3 d/week) involving a specific lumbar extension exercise on the Roman bench and four complementary exercises to improve core strength and spine stabilization.
Participants will receive LED PBMT 30 minutes before each training session, through a device containing 264 LEDs, which will be placed on the lumbar region (between L1 and L5).
|
Placebo Comparator: Lumbar strengthening training combined with placebo PBMT (TR+PLA)
Each participant will be submitted to a 8-wk lumbar strengthening training program and will receive the placebo PBMT 30 minutes before each training session.
|
Participants will be submitted to a supervised 8-wk training program (3 d/week) involving a specific lumbar extension exercise on the Roman bench and four complementary exercises to improve core strength and spine stabilization.
Participants will receive placebo PBMT 30 minutes before each training session, through a off-line device (turned off) containing 264 LEDs, which will be placed on the lumbar region (between L1 and L5).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in postural balance
Time Frame: Baseline and after 8 weeks
|
Postural balance will be assessed on a force platform at pre- and post-training
|
Baseline and after 8 weeks
|
Change in low back pain
Time Frame: Baseline and after 8 weeks
|
Low back pain will be assessed with a visual analogue scale (VAS) at pre- and post-training
|
Baseline and after 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Tampa Scale of kinesiophobia (TSK)
Time Frame: Baseline and after 8 weeks
|
The TSK is a 17-item self report checklist using a 4-point Likert scale that was developed as a measure of fear of movement or injury.
|
Baseline and after 8 weeks
|
Fear-Avoidance Beliefs Questionnaire (FABQ)
Time Frame: Baseline and after 8 weeks
|
The FABQ is a patient reported questionnaire which specifically focuses on how a patient's fear avoidance beliefs about physical activity and work may affect and contribute to their low back pain and resulting disability.
|
Baseline and after 8 weeks
|
Pain Catastrophizing Scale (PCS)
Time Frame: Baseline and after 8 weeks
|
PCS is a instrument used for measuring catastrophic thinking related to pain.
|
Baseline and after 8 weeks
|
Oswestry Disability Index (ODI)
Time Frame: Baseline and after 8 weeks
|
ODI is a questionnaire used to assess the subjective percentage score of level of function (disability) in activities of daily living in those rehabilitating from low back pain.
|
Baseline and after 8 weeks
|
Roland Morris Disability Questionnaire (RMDQ)
Time Frame: Baseline and after 8 weeks
|
RMDQ questionnaire is designed to assess self-rated physical disability caused by low back pain
|
Baseline and after 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2022
Primary Completion (Actual)
July 30, 2022
Study Completion (Actual)
November 30, 2022
Study Registration Dates
First Submitted
May 13, 2021
First Submitted That Met QC Criteria
May 13, 2021
First Posted (Actual)
May 17, 2021
Study Record Updates
Last Update Posted (Actual)
September 13, 2023
Last Update Submitted That Met QC Criteria
September 8, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Photobiomodulation project
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Children's National Research InstituteRecruitingProfessional Quality of LifeUnited States
-
Istituto Ortopedico RizzoliUniversity of BolognaActive, not recruitingImprove Quality of LifeItaly
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
-
Linkoeping UniversityRecruiting
-
South Valley UniversityActive, not recruitingDeterminants of Health-related Quality of Life for Patients After Renal Lithotripsy: PNL Versus RIRSHealth Related Quality of LifeEgypt
-
Region VästmanlandUnknownHealth Related Quality of Life
Clinical Trials on strengthening training and LED PBMT
-
Academic Centre for Dentistry in AmsterdamNot yet recruitingMultiple Myeloma
-
Musculoskeletal Injury Rehabilitation Research...The Geneva Foundation; Uniformed Services University (USU) of the Health Sciences and other collaboratorsNot yet recruitingLow-Level Laser Therapy | Photobiomodulation Therapy | Performance Enhancement | Photomedicine | Quadriceps | Special Operations Readiness
-
Universidade Norte do ParanáUniversidade Estadual de MaringáCompletedLow Back Pain | Hydrotherapy | Exertion; ExcessBrazil
-
Universidade Federal de Sao CarlosCompletedMusculoskeletal Pain | Muscle Damage | Injury Prevention | Sports PerformanceBrazil
-
Lydia WillemseKU Leuven; Tilburg University; Fontys University of Applied SciencesRecruitingFall RiskNetherlands
-
Muğla Sıtkı Koçman UniversityCompleted
-
Pamukkale UniversityCompleted
-
Wang Yongtai RaymondThe N.1 Institute for Health (N.1)Not yet recruiting
-
LMU KlinikumGerman Research FoundationRecruitingSchizophrenia | Exercise | Neuronal PlasticityGermany